Our portfolio

Next-generation healthy gut microbiome products

Evolve BioSystems, a microbiome company, is developing the next generation of products to establish, restore, and maintain a healthy gut microbiome. The foundation is backing Evolves further development of its lead probiotic Evivo to support healthy growth and development, and prevent infection in infants in developing countries.
Website
  • Domain
    Agriculture & Nutrition
  • Investment type
    Direct equity
  • Status
    Active
  • Initial investment
    Series C
  • Partnered in
    2018
  • Investment lead
    Ryan Kreitzer
  • Headquarters
    USA
  • Program strategy
    Maternal & Newborn Child Health

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.